What top creators are saying about Anthropic(ANTHROPIC)

Serves as a high-conviction core institutional holding representing approximately 2.5% of Baylor University's endowment for concentrated exposure to foundation AI models.

Capturing significant value accrual in private frontier AI markets, drawing strong institutional liquidity demand ahead of potential public market access.

Raised ~$72B in funding and entered into a ~$40B infrastructure rental agreement with xAI.

Author advises caution regarding the upcoming IPO due to an aggressive $2 trillion target valuation, potential VC share dumping, LLM commoditization, and expected high volatility.

Revenue growth flatlined due to compute capacity bottlenecks and performance slowdowns, needing significant revenue expansion to offset high compute costs.

Demonstrating unprecedented top-line growth with run-rate revenue scaling to $65 billion driven by enterprise AI agents, though long-term margins face potential open-source competition.

Preparing for an IPO with revenue growing rapidly to an annualized run rate of $46 billion and targeting a valuation up to $2 trillion, though analysts caution about steep profit requirements to justify that multiple.

Accessible as a private pre-IPO investment through SPVs, requiring rigorous due diligence on fund intermediaries and holding terms.

Cited as a centralized AI model provider that investors should seek decentralized alternatives to.

Expresses caution regarding high valuations in the current market environment

Released Sonnet 5 as an efficiency play for high-volume tasks, though pricing is scheduled to increase in September.

Faces risks of commoditization in the 'model layer' and potential underperformance relative to compute-advantaged competitors.

Building a 'trust moat' through close ties with U.S. intelligence despite IP risks from competitors like Alibaba.

Potential for options trading as a tokenized asset on the Hyperliquid ecosystem.

Part of the AI trend seeing high interest but potentially unsustainable valuation chasing.

Facing significant regulatory risk and margin pressure; government intervention recently disabled its Fable 5 model.

Highlighted as a leader in the AI space that is reportedly showing positive EBITDA before its potential IPO.

Anticipated to be a major focus for traders following upcoming IPO activity.

Anticipated upcoming IPO expected to draw significant market attention.

Focus is shifting away from Anthropic's speculated IPO toward Chinese AI developments.

Facing heavy regulatory headwinds, including export controls and mandatory KYC, which limits its global market reach.

The focus is shifting toward token efficiency and specialized models like Sonnet to manage costs and environmental impact.

Identified as a key player in the collective commitment to drive AI education.

Mentioned as part of the expanding pre-IPO asset markets on the Hyperliquid DEX.

Potential IPO is viewed as a major catalyst for trading activity in related synthetic markets.

Included in Hyperliquid's pre-IPO market expansion.

Interest in pre-IPO markets for high-profile AI companies is driving volume and sentiment within the platform.

Facing significant regulatory friction, export control hurdles, and complex relationship issues with its partner Amazon.

Part of the group of private companies that may see price exposure via new CFTC/SEC regulated perpetual instruments.

Preferred over OpenAI due to enterprise/coding focus and ability to attract top-tier talent like Andrej Karpathy.

High reliance on Claude's coding capabilities and Model Context Protocol (MCP) to drive agentic loops and complex tool interactions.

High-valuation AI startup at risk of having its primary product commoditized by Google; also mentioned as a risk for public investors if it IPOs at a late-stage valuation peak.

Face significant competitive pressure from Google; public investors should exercise caution regarding future IPO valuation vs. actual upside.

Viewed as a late-stage venture opportunity within the critical AI infrastructure sector.

Filed for a confidential IPO; successfully pivoted to the enterprise market with rapid valuation growth and high momentum.

Seeing strong enterprise adoption and recognized as a frontier lab with high defensibility.

Massive revenue surge suggests enterprise scaling of agentic AI, despite some niche prompt-adherence weaknesses.

Mentioned as a key player attracting concentrated liquidity in the AI sector.

Expected to pay xAI for infrastructure rental while facing higher capital costs than integrated competitors.

Upcoming IPO filing is identified as a potential indicator of an AI peak and subsequent market correction.

Forming a powerful duopoly with SpaceX for compute; paying $15 billion annually for data center access and attracting top talent from rivals.

Seeking to go public by this fall to capitalize on the AI trade.

Identified as a key pre-IPO trading asset for the upcoming Q3-Q4 season.

Company is actively nullifying secondary market trades made without board approval; high risk of fraud in unofficial SPV channels.

High demand in secondary markets but faces risks from unauthorized deals, complex SPV structures, and forward contract defaults.

Company is refusing to recognize secondary market SPVs, creating risks for private equity investors.

Experiencing massive ARR growth and focusing on high-value enterprise software vulnerabilities.

Positioned as a safe alternative to OpenAI; scaling massive compute capacity and achieving 52x speedup in code optimization.

Risk of customers switching to competitors if compute runs out; advised to wait for public market entry.

Launched a joint venture for Forward Deployed Engineering to embed engineers directly into clients, specifically targeting healthcare and finance.